Provided by Tiger Trade Technology Pte. Ltd.

Novo-Nordisk A/S

44.01
-0.5500-1.23%
Pre-market: 43.44-0.5700-1.30%09:03 EDT
Volume:6.58M
Turnover:291.64M
Market Cap:196.50B
PE:10.99
High:44.82
Open:44.60
Low:44.01
Close:44.56
52wk High:64.16
52wk Low:35.12
Shares:4.47B
Float Shares:3.19B
Volume Ratio:0.69
T/O Rate:0.21%
Dividend:1.72
Dividend Rate:3.91%
EPS(TTM):4.00
EPS(LYR):3.62
ROE:59.82%
ROA:18.73%
PB:6.03
PE(LYR):12.16

Loading ...

Novo Nordisk Launches Weekly Insulin Shot Awiqli in India

Reuters
·
Jul 09

Novo Nordisk A/S Stock Falls Wednesday, Outperforms Market

Dow Jones
·
Jul 09

Novo Nordisk announces updated semaglutide label in Singapore

TIPRANKS
·
Jul 08

It Can Take as Little as 5 Minutes Online to Get Prescribed a GLP-1 for Weight Loss. Why That's Risky.

Dow Jones
·
Jul 08

Race to Launch Weight-loss Pills Heats up as Smaller Players Advance

Reuters
·
Jul 08

Weight-loss Drug Developers Line up to Tap Lucrative Market as Competition Heats Up

Reuters
·
Jul 07

Terry Smith dubs weight-loss giant Novo Nordisk ‘investment disaster’

cityam
·
Jul 07

Sector Update: Healthcare

MT Newswires Live
·
Jul 07

Vivani Advances GLP-1 Implant Program With Novo Nordisk

TIPRANKS
·
Jul 07

Vivani Medical Enters into Agreement with Novo Nordisk to Evaluate NPM-139, a Miniature, Ultra Long-Acting Semaglutide Implant for Chronic Weight Management

GlobeNewswire
·
Jul 07

Option traders moderately bearish in Novo Nordisk with shares down 2.31%

TIPRANKS
·
Jul 07

Novo Nordisk A/S Stock Falls Monday, Underperforms Market

Dow Jones
·
Jul 07

European Equities Traded in the US as American Depositary Receipts Rise in Monday Trading

MT Newswires Live
·
Jul 06

Novo Nordisk price target raised to DKK 300 from DKK 280 at HSBC

TIPRANKS
·
Jul 06

Intraday Alert|Novo Nordisk Falls 3.05% in Regular Trading, Trading at $48.80

Market Focus
·
Jul 06

Trump’s FDA May Soon Throw Its Weight Behind Peptides. Should You Buy In?

Macro World​
·
Jul 06

Trump's FDA May Soon Throw Its Weight Behind Peptides. Should You Buy In?

Dow Jones
·
Jul 05

Novo Nordisk (NVO) Wins UK Wegovy Pill Approval As Medicare Opens GLP 1 Access

Simply Wall St.
·
Jul 04

Novo Nordisk A/S Stock Falls Friday, Underperforms Market

Dow Jones
·
Jul 04

Movement Alert|Novo Nordisk Rises 3.09% in Regular Trading, Medicare Coverage of Weight-Loss Drugs and Supply Chain Cost Optimization Boost Shares

Market Focus
·
Jul 02